Back to search

France· FR:62583314

VITAMINE A PROVEPHARM 100 000 U.I./2 ml, solution injectable (I.M.)

A medicinal product containing palmitate de rétinol, registered in France by PROVEPHARM, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedVITAMINE A PROVEPHARM 100 000 U.I./2 …ATC—REGISTER NO.FR:62583314PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
PALMITATE DE RÉTINOL
Manufacturer
PROVEPHARM
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400935653178
    6 ampoule(s) en verre brun de 2 ml
    EUR 22.69

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Palmitate de rétinol in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palmitate de rétinol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Spain · Auxina A Masiva
  • Poland · Maść Ochronna Z Witaminą A
  • Portugal · A-Vite

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4376ff3d-5597-4c94-a389-03fd98444577
GET /v1/drugs/4376ff3d-5597-4c94-a389-03fd98444577?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62583314",
  "date_amm": "1997-10-28",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "substance": "PALMITATE DE RÉTINOL",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution injectable",
  "voies_administration": "intramusculaire",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about palmitate de rétinol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.